Aspira Pathlab & Diagnostics standalone net profit rises 85.86% in the September 2025 quarter

Sales rise 30.91% to Rs 8.09 crore

Net profit of Aspira Pathlab & Diagnostics rose 85.86% to Rs 1.84 crore in the quarter ended September 2025 as against Rs 0.99 crore during the previous quarter ended September 2024. Sales rose 30.91% to Rs 8.09 crore in the quarter ended September 2025 as against Rs 6.18 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	8.09	6.18	31
OPM %	27.19	21.84	-
PBDT	2.24	1.35	66
PBT	1.84	0.99	86
NP	1.84	0.99	86

Powered by Capital Market - Live News